International Battery Metals Ltd. Announced RSU Grant
VANCOUVER, BC AND HOUSTON, TX / ACCESS Newswire / May 14, 2026 / International Battery Metals Ltd. ("IBAT") (TSXV:IBAT)(OTCQB: IBATF), an advanced technology provider of modular direct lithium extraction (DLE) systems, today announced that the Board of Directors approved the grant of 500,000 restricted share units of the Company ("RSUs") to Norma Garcia, General Counsel and Corporate Secretary. The RSUs will vest in equal installments on the annual anniversary of the date of grant over a three-year period from the date of grant, and once vested, each RSU will settle into one common share of the Company. The RSUs are subject to the terms of Company's equity compensation plan, applicable securities law holding periods and the policies of the TSX Venture Exchange (the "TSXV").
About International Battery Metals Ltd.
IBAT's direct lithium extraction technology is based on proprietary lithium extraction media housed in patented extraction columns. The columns are enclosed in modular, transportable skid mounted platforms that can be transported and commissioned into production within a reasonably short time frame.
Utilizing the patented technology, the Company's focus has been on advancing extraction of lithium chloride from ground water salt brine and produced water deposits. The Company's unique patented technology ensures efficient delivery of lithium chloride while ensuring minimal environmental impact.
Neither the TSXV, the OTCQB nor their respective Regulation Services Providers accept responsibility for the adequacy or accuracy of this news release.
Contacts
Investor Relations contacts:
Brian Siegel, IRC, MBA
Senior Managing Director
Hayden IR
(346) 396-8696
[email protected]
SOURCE: International Battery Metals Ltd.
View the original press release on ACCESS Newswire
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ROK Resources Files Financial Results and Management Discussion & Analysis for Second Quarter of 2026
- Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Letter of Intent with Darmiyan, Inc. to Explore Use of FDA De Novo Authorized BrainSee(R) AI Platform in Early Alzheimer's Disease
- STLLR Gold Welcomes Proposed Arctic Economic and Security Corridor Alignment, Highlighting Potential Strategic Benefits to the Colomac Gold Project
Create E-mail Alert Related Categories
ACCESS Newswire, Press ReleasesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share